Cited by 70COVID-19 Clinical Research StudiesSepsis Diagnosis and TreatmentLong-Term Effects of COVID-19

Blood lactate concentration in COVID-19: a systematic literature review

Open access
Carpenè, Giovanni, Onorato, Diletta, Nocini, Riccardo, Fortunato, Gianmarco, Rizk, John G., Henry, Brandon M., Lippi, Giuseppe·2022·Clinical Chemistry and Laboratory Medicine (CCLM)

Abstract

Coronavirus disease 2019 (COVID-19) is an infectious respiratory condition sustained by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which manifests prevalently as mild to moderate respiratory tract infection. Nevertheless, in a number of cases the clinical course may deteriorate, with onset of end organ injury, systemic dysfunction, thrombosis and ischemia. Given the clinical picture, baseline assessment and serial monitoring of blood lactate concentration may be conceivably useful in COVID-19. We hence performed a systematic literature review to explore the possible association between increased blood lactate levels, disease severity and mortality in COVID-19 patients, including comparison of lactate values between COVID-19 and non-COVID-19 patients. We carried out an electronic search in Medline and Scopus, using the keywords “COVID-19” OR “SARS-CoV-2” AND “lactate” OR “lactic acid” OR “hyperlactatemia”, between 2019 and present time (i.e. October 10, 2021), which allowed to identify 19 studies, totalling 6,459 patients. Overall, we found that COVID-19 patients with worse outcome tend to display higher lactate values than those with better outcome, although most COVID-19 patients in the studies included in our analysis did not have sustained baseline hyperlactatemia. Substantially elevated lactate values were neither consistently present in all COVID-19 patients who developed unfavourable clinical outcomes. These findings suggest that blood lactate monitoring upon admission and throughout hospitalization may be useful for early identification of higher risk of unfavourable COVID-19 illness progression, though therapeutic decisions based on using conventional hyperlactatemia cut-off values (i.e., 2.0 mmol/L) upon first evaluation may be inappropriate in patients with SARS-CoV-2 infection.

Integrity signals

Registry

Crossref · 10.1515/cclm-2021-1115

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Interpretation of LDH results may be difficult in COVID-19 patients, as both lactate and LDH were also found to be independent risk factors of severe forms of COVID-19.

    “However, interpretation of the results may be difficult in COVID-19 patients, as both lactate and LDH were also found to be independent risk factors of severe forms of COVID-19 [57,58].”

    From Acute mesenteric ischemia in COVID-19 patients (2021) · cites this paper as [58]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Carpenè, G., Onorato, D., Nocini, R., Fortunato, G., Rizk, J. G., Henry, B. M., & Lippi, G.
Affiliations
  • University of Verona (IT)
  • Arizona State University (US)
  • Cincinnati Children's Hospital Medical Center (US)
Corresponding author
Lippi, Giuseppe
Venue
Clinical Chemistry and Laboratory Medicine (CCLM)
Published
2021-12-02
Volume
60
Issue
3
Pages
332-337
ISSN
  • 1434-6621 (ISSN-L)
  • 1437-4331
OpenAlex
W3216188313
Cited by
68
References
31
Citations by year
2026: 5 · 2025: 7 · 2024: 26 · 2023: 17 · 2022: 12 · 2021: 1
FWCI
1.70
Type
journal article
Language
en
Licence
other-oa
Locations
  • Clinical Chemistry and Laboratory Medicine (CCLM) (publishedVersion)
  • PubMed (publishedVersion)
  • INFM-OAR (INFN Catania) (submittedVersion, other-oa)
  • Zenodo (CERN European Organization for Nuclear Research) (other-oa)
Topics
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Health Sciences › Medicine › Epidemiology › Sepsis Diagnosis and Treatment
  • Health Sciences › Medicine › Neurology › Long-Term Effects of COVID-19
Keywords
COVID-19 pandemic, SARS-CoV-2, blood lactate, hyperlactatemia, disease severity, mortality, lactate monitoring, prognostic factors, cut-off values
MeSH terms
COVID-19, SARS-CoV-2, Hospitalization, Humans, Lactic Acid, Hyperlactatemia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review